Literature DB >> 454456

Enzyme inhibition titration assay for 2'-deoxycoformycin and its application to the study of the relationship between drug concentration and tissue adenosine deaminase in dogs and rats.

M M Chassin, R H Adamson, D W Zaharevitz, D G Johns.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 454456     DOI： 10.1016/0006-2952(79)90636-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Physiologic model for the pharmacokinetics of 2'deoxycoformycin in normal and leukemic mice.

Authors:  F G King; R L Dedrick
Journal:  J Pharmacokinet Biopharm       Date:  1981-10

Review 2.  Adenosine deaminase inhibitors: their role in chemotherapy and immunosuppression.

Authors:  R I Glazer
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

Review 3.  Pentostatin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in lymphoproliferative disorders.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Deoxycoformycin: neurological toxicity.

Authors:  P P Major; R P Agarwal; D W Kufe
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

5.  The clinical pharmacology of the adenosine deaminase inhibitor 2'-deoxycoformycin.

Authors:  J F Smyth; R M Paine; A L Jackman; K R Harrap; M M Chassin; R H Adamson; D G Johns
Journal:  Cancer Chemother Pharmacol       Date:  1980       Impact factor: 3.333

6.  Animal model for immune dysfunction associated with adenosine deaminase deficiency.

Authors:  A Tedde; M E Balis; S Ikehara; R Pahwa; R A Good; P P Trotta
Journal:  Proc Natl Acad Sci U S A       Date:  1980-08       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.